BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18844613)

  • 21. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.
    Konikoff MR; Noel RJ; Blanchard C; Kirby C; Jameson SC; Buckmeier BK; Akers R; Cohen MB; Collins MH; Assa'ad AH; Aceves SS; Putnam PE; Rothenberg ME
    Gastroenterology; 2006 Nov; 131(5):1381-91. PubMed ID: 17101314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.
    Straumann A; Bauer M; Fischer B; Blaser K; Simon HU
    J Allergy Clin Immunol; 2001 Dec; 108(6):954-61. PubMed ID: 11742273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
    Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
    J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
    Sayej WN; Patel R; Baker RD; Tron E; Baker SS
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-5 promotes eosinophil trafficking to the esophagus.
    Mishra A; Hogan SP; Brandt EB; Rothenberg ME
    J Immunol; 2002 Mar; 168(5):2464-9. PubMed ID: 11859139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.
    Blanchard C; Wang N; Stringer KF; Mishra A; Fulkerson PC; Abonia JP; Jameson SC; Kirby C; Konikoff MR; Collins MH; Cohen MB; Akers R; Hogan SP; Assa'ad AH; Putnam PE; Aronow BJ; Rothenberg ME
    J Clin Invest; 2006 Feb; 116(2):536-47. PubMed ID: 16453027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease.
    Tantibhaedhyangkul U; Tatevian N; Gilger MA; Major AM; Davis CM
    Ann Clin Lab Sci; 2009; 39(2):99-107. PubMed ID: 19429794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of phoshpodiesterase 4 (PDE4) inhibibtors on eotaxin expression in humen bronchial epithelial cells.
    Paplinska M; Chazan R; Grubek-Jaworska H
    J Physiol Pharmacol; 2011 Jun; 62(3):303-11. PubMed ID: 21893690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.
    Helou EF; Simonson J; Arora AS
    Am J Gastroenterol; 2008 Sep; 103(9):2194-9. PubMed ID: 18637093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time RT-PCR quantification of mRNA encoding cytokines, CC chemokines and CCR3 in bronchial biopsies from dogs with eosinophilic bronchopneumopathy.
    Peeters D; Peters IR; Clercx C; Day MJ
    Vet Immunol Immunopathol; 2006 Mar; 110(1-2):65-77. PubMed ID: 16226318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in serum eotaxin and eosinophil cationic protein levels, and eosinophil count during treatment of childhood asthma.
    Chu YT; Chiang W; Wang TN; Hung CH; Jong YJ; Wu JR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):162-7. PubMed ID: 17446966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils.
    Han SJ; Kim JH; Noh YJ; Chang HS; Kim CS; Kim KS; Ki SY; Park CS; Chung IY
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):303-10. PubMed ID: 10460747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of local cytokine gene expression in patients with allergic rhinitis treated with CO2 laser surgery.
    Takeno S; Osada R; Furukido K; Yajin K
    Laryngoscope; 2000 Nov; 110(11):1968-74. PubMed ID: 11081620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect and mechanism of lipopolysaccharide on allergen-induced interleukin-5 and eotaxins production by whole blood cultures of atopic asthmatics.
    Min JW; Park SM; Rhim TY; Park SW; Jang AS; Uh ST; Park CS; Chung IY
    Clin Exp Immunol; 2007 Mar; 147(3):440-8. PubMed ID: 17302892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-4-mediated infiltration of eosinophils into the conjunctiva and its suppression by interferon-gamma.
    Fukushima A; Jian Z; Ishida W; Fukata K; Ozaki A; Ueno H
    Curr Eye Res; 2005 Feb; 30(2):115-22. PubMed ID: 15814469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma.
    Larose MC; Chakir J; Archambault AS; Joubert P; Provost V; Laviolette M; Flamand N
    J Allergy Clin Immunol; 2015 Oct; 136(4):904-13. PubMed ID: 25936567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibitory effects of Galectin-3 on the inflammatory cytokines and chemokines in guinea pig asthma models].
    Li L; Liu CT; Wang K; Pang YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):355-8. PubMed ID: 15931867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.